Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China. [PDF]
Li X, Wang L, Li D, Niu J, Gao P.
europepmc +1 more source
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery. [PDF]
Peta V+24 more
europepmc +1 more source
Highlight report: prediction of drug induced liver injury (DILI) with human hepatocytes in vitro [PDF]
openaire +3 more sources
Natural History of Idiosyncratic Drug-Induced Liver Injury and Prognostic Models. [PDF]
Devarbhavi HC, Andrade RJ.
europepmc +1 more source
Mechanisms of drug induced liver injury. [PDF]
Skat-Rørdam J+3 more
europepmc +1 more source
Drug Reaction With Eosinophilia and Systemic Symptoms and Severe Drug-Induced Liver Injury After Off-Label Zonisamide Use for Weight Loss. [PDF]
Sadjadi R+6 more
europepmc +1 more source
Hemophagocytic Lymphohistiocytosis Complicating a Case of Drug-Induced Liver Injury Precipitated by Cephalexin: A Rare Consequence of Commonly Prescribed Medications. [PDF]
Newman MT+6 more
europepmc +1 more source
Incidence, Clinical Features, Associated Factors and Outcomes of Intensive Phase Antituberculosis Drug Induced Liver Injury Among Patients With Tuberculosis at a Tertiary Care Hospital in Nepal: A Descriptive Cross-Sectional Study. [PDF]
Pradhan RR, Yadav AK.
europepmc +1 more source
Clinical Features of Anti-Tuberculosis Drug-Induced Liver Injury and Risk Factors for Severe Cases: A Retrospective Study in China. [PDF]
Zhang S, Dong N, Wang L, Lu Y, Chen X.
europepmc +1 more source